Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gene therapy with Adv-IL-2 in unresectable digestive cancer: phase I-II study, intermediate report.
Gilly FN, Beaujard A, Bienvenu J, Trillet Lenoir V, Glehen O, Thouvenot D, Malcus C, Favrot M, Dumontet C, Lombard-Bohas C, Garbit F, Gueugniaud PY, Vignal J, Aymard M, Touraine Moulin F, Roos M, Pavirani A, Courtney M. Gilly FN, et al. Among authors: malcus c. Hepatogastroenterology. 1999 May;46 Suppl 1:1268-73. Hepatogastroenterology. 1999. PMID: 10429973 Clinical Trial. No abstract available.
[Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
Bellon G, Calmard L, Thouvenot D, Levrey H, Jagneaux V, Poitevin F, Malcus C, Accart N, Séné C, Layani MP, Aymard M, Bienvenu J, Courtney M, Döring G, Gilly B, Gilly R, Lamy D, Morel Y, Paulin C, Perraud F, Rodillon L, So S, Touraine F, Schatz C, Pavirani A. Bellon G, et al. Among authors: malcus c. C R Seances Soc Biol Fil. 1996;190(1):109-42. C R Seances Soc Biol Fil. 1996. PMID: 8881273 Clinical Trial. French.
Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial.
Bellon G, Michel-Calemard L, Thouvenot D, Jagneaux V, Poitevin F, Malcus C, Accart N, Layani MP, Aymard M, Bernon H, Bienvenu J, Courtney M, Döring G, Gilly B, Gilly R, Lamy D, Levrey H, Morel Y, Paulin C, Perraud F, Rodillon L, Sené C, So S, Touraine-Moulin F, Pavirani A, et al. Bellon G, et al. Among authors: malcus c. Hum Gene Ther. 1997 Jan 1;8(1):15-25. doi: 10.1089/hum.1997.8.1-15. Hum Gene Ther. 1997. PMID: 8989991 Clinical Trial.
Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.
Morelon E, Lefrançois N, Besson C, Prévautel J, Brunet M, Touraine JL, Badet L, Touraine-Moulin F, Thaunat O, Malcus C. Morelon E, et al. Among authors: malcus c. Transpl Immunol. 2010 May;23(1-2):53-8. doi: 10.1016/j.trim.2010.04.004. Epub 2010 Apr 18. Transpl Immunol. 2010. PMID: 20406686 Clinical Trial.
PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.
Mathieu AL, Verronese E, Rice GI, Fouyssac F, Bertrand Y, Picard C, Chansel M, Walter JE, Notarangelo LD, Butte MJ, Nadeau KC, Csomos K, Chen DJ, Chen K, Delgado A, Rigal C, Bardin C, Schuetz C, Moshous D, Reumaux H, Plenat F, Phan A, Zabot MT, Balme B, Viel S, Bienvenu J, Cochat P, van der Burg M, Caux C, Kemp EH, Rouvet I, Malcus C, Méritet JF, Lim A, Crow YJ, Fabien N, Ménétrier-Caux C, De Villartay JP, Walzer T, Belot A. Mathieu AL, et al. Among authors: malcus c. J Allergy Clin Immunol. 2015 Jun;135(6):1578-88.e5. doi: 10.1016/j.jaci.2015.01.040. Epub 2015 Apr 2. J Allergy Clin Immunol. 2015. PMID: 25842288 Free PMC article.
Mesenchymal stem cell and immunosuppressive drug interactions.
Buron F, Morelon E, Perrin H, Malcus C, Moulin FT, Héquet O. Buron F, et al. Among authors: malcus c. Transplantation. 2009 Jun 27;87(12):1899-900; discussion 1900-1. doi: 10.1097/TP.0b013e3181a99079. Transplantation. 2009. PMID: 19543073 No abstract available.
73 results